Keck USC Diabetes Symposium 2025

Description

+ Include: 12 videos 

+ Target Audience: endocrinologists, primary care physicians, hospitalists, advanced practice providers

+ Information:

The USC Diabetes Symposium returns for its 4th year, continuing to provide exciting updates in the care of people with diabetes, as well as the accompanying complications and comorbidities.  This hybrid program, offered in person and over virtual platform, presents updates in the field of diabetes and obesity management from experts in a variety of fields.  Highlighted are areas of advancement including updates to guideline-based medical therapy, management of peripheral neuropathy, strategies for reducing of cardiovascular risk, managing diabetes in the inpatient setting and in the geriatric population, updates in diabetes technology and discussion of cutting-edge therapies such as new bariatric procedures and weekly insulin.

1. Identify patients who are candidates for cardio- and renal-protective medications.
2. Summarize the benefits of once-weekly insulin therapy.
3. Treat obesity in the context of diabetes.
4. Integrate strategies for reduction of polypharmacy.

The Keck USC Diabetes Symposium 2025 is best for endocrinologists, primary care physicians, hospitalists, advanced practice providers, and allied health professionals who want CME‑accredited updates on the latest advances in diabetes care, including new therapies, technologies, and multidisciplinary management strategies.

 Who Should Attend

• Endocrinologists and diabetologists managing complex diabetes cases.
• Primary care physicians and family medicine doctors who provide frontline diabetes care.
• Hospitalists and internists treating patients with diabetes complications.
• Nurse practitioners and physician assistants working in outpatient or inpatient diabetes management.
• Pharmacists, dietitians, and diabetes educators involved in patient counseling and therapy optimization.
• Residents and fellows in endocrinology or internal medicine preparing for board exams or expanding their clinical knowledge.

+ Topics:

• 01 What’s New in Type 2 Diabetes An ADA 2025 Guidelines Update
• 02 Frontiers in Insulin Therapy Once-Weekly Basal Insulin
• 03 Advances in Surgical and Endoscopic Therapies for Type
• 04 Questions and Answers Session I
• 05 Lipid-Lowering Therapies in Type 2 Diabetes Are We Doing Enough
• 06 Diabetes in Older Adults Special Considerations for the Geriatric Population
• 07 Management of Painful Diabetic Neuropathy
• 08 Questions and Answers Session II
• 09 Diabetes Tech in 2025
• 10 Inpatient Hyperglycemia Management
• 11 Ask the Experts Challenging Cases in T2DM
• 12 Questions and Answers Session III